Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Cytosorbents Corp | tm205298d1_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Cytosorbents Corp | tm205298d1_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Cytosorbents Corp | tm205298d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Cytosorbents Corp | tm205298d1_ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - Cytosorbents Corp | tm205298d1_ex21-1.htm |
| EX-4.1 - EXHIBIT 4.1 - Cytosorbents Corp | tm205298d1_ex4-1.htm |
| 10-K - FORM 10-K - Cytosorbents Corp | tm205298-1_10k.htm |
Exhibit 23.1
CONSENT OF REGISTERED INDEPENDENT PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference of our reports dated March 5, 2020 relating to the consolidated financial statements of Cytosorbents Corporation (the “Company”) as of December 31, 2019 and 2018 and for each of the three years in the period ended December 31, 2019 and the effectiveness of the Company’s internal control over financial reporting which appears in this annual report on Form 10-K into the Company’s previously filed Registration Statements on Forms S-3 (Registration Nos. 333-226372, 333-194394, 333-193053, and 333-205806) and Forms S-8 (Registration Nos. 333-220630, 333-199852, and 333-203244) and to the reference to our Firm under the caption “Experts”.
/s/ WithumSmith+Brown, PC
East Brunswick, New Jersey
March, 5, 2020